News

Alvotech, the Iceland-based biosimilar company, announced that the first patient has been dosed in the comparative, confirmatory efficacy and safety clinical study (AVT04-GL-301) for AVT04, Alvotech's proposed biosimilar to the reference product Stelara®. The objective of the study is...

Zydus Cadila announced that the company has applied for EUA to the office of Drug Controller General of India (DCGI) for ZyCoV-D -its Plasmid DNA Vaccine against COVID-19. The company conducted the largest clinical trial for its COVID-19 vaccine...

Menzies Aviation, the global aviation logistics specialist, is delighted to announce that its cargo operations have received a further Center of Excellence of Independent Validators for Pharmaceutical Logistics accreditation (“CEIV Pharma”) as recognised by IATA. This accreditation is for...

July 6, 1885 was a historic date for modern medicine and treatment. This was the day when Louis Pasteur administered the first attenuated vaccine to a human patient. Over the next 135 years, the development of vaccines for various...

Roche is teaming up with Mimetas, a provider of organ-on-chip-based disease model to develop human disease models to characterize novel compounds in inflammatory bowel disease (IBD) and hepatitis B virus infections (HBV). The collaboration will see Mimetas developing tissue-based disease...

Morepen Laboratories has started production of the test batch of Russia's Sputnik V Covid-19 vaccine at its facility in Himachal Pradesh, Russian Direct Investment Fund (RDIF) and the domestic drug firm said in a statement. The first batch will be...

BioMed X, a leading independent research institute, announced the start of its eighth joint research program with Merck KGaA, Darmstadt, Germany. The new program will explore the role of extrachromosomal DNA in cancer and it will complement the research...